Pancreatic Neoplasms: all 3,310 studies
Page 30 of 34. Open to participants first (910), then studies with results posted, then the rest; newest registration first within each.
- Evaluation of Isolated Roux-en-Y Reconstruction After PancreaticoduodenectomyStatus unknownNCT00915863Not applicable
- NC-6004(Nanoplatin) and Gemcitabine to Treat Pancreatic Cancer in AsiaCompletedNCT00910741Phase 1/2
- Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on CancerSuspendedNCT00909558Phase 1
- A Phase I/II Open-Label Dose-Escalation Clinical Trial of CPI-613 in Combination With Gemcitabine in Cancer PatientsTerminatedNCT00907166Phase 1/2
- Fatigue and Pancreas and Bile Duct Cancer StudyCompletedNCT00902759Early Phase 1
- Nurse-Provided Care or Standard Care in Treating Patients With Pancreatic CancerCompletedNCT00902733Not applicable
- A Study of AGS-1C4D4 Given in Combination With Gemcitabine in Subjects With Metastatic Pancreatic CancerCompletedNCT00902291Phase 2
- UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With CancerCompletedNCT00900094
- Studying Fibroblast Activity in Patients With Localized Pancreatic Cancer Undergoing SurgeryCompletedNCT00900016
- Studying Biomarkers in Patients With Pancreatic CancerCompletedNCT00900003
- Biological Markers in Patients With Pancreatic Cancer Experiencing Weight LossCompletedNCT00899158
- Studying a Tumor Marker for Testicular Cancer, Skin Cancer, Small Intestine Cancer, and Pancreatic CancerTerminatedNCT00899132
- Study of Circulating Cancer Cells in Patients With Metastatic Breast, Ovarian, Colon, or Pancreatic CancerTerminatedNCT00898781
- Collecting and Storing Samples of Blood From Patients With Pancreatic Cancer and Healthy ParticipantsCompletedNCT00898482
- Safety and Efficacy Study of P276-00 in Combination With Gemcitabine in Patients With Advanced Pancreatic CancerCompletedNCT00898287Phase 1/2
- Biomarkers in Predicting Response to Treatment in Patients Who Have Undergone Surgery for Pancreatic CancerCompletedNCT00897832
- Gene Expression Profiles in Patients With Metastatic Pancreatic CancerCompletedNCT00897741
- Identification of Biomarkers for Early Detection of Pancreatic CancerCompletedNCT00897494
- Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial TherapyTerminatedNCT00896467
- Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous TherapyCompletedNCT00892736Phase 1
- Perioperative Treatment With Zoledronic Acid in Patients With Resectable Pancreas CancerTerminatedNCT00892242Phase 1
- Integrated Positron Emission Tomography - Computed Tomography (PET-CT) in Patients With Pancreatic CancerStatus unknownNCT00885248
- Gemcitabine, Capecitabine, and Erlotinib in Treating Patients With Advanced Pancreatic CancerCompletedNCT00885066Phase 1
- Trial to Determine the Maximum Tolerated Dose of Genexol-PM Plus Gemcitabine and Evaluate Efficacy and Safety of Genexol-PM Regimens in Subjects With Advanced Pancreatic CancerCompletedNCT00882973Phase 1
- Genistein in Treating Patients With Pancreatic Cancer That Can Be Removed by SurgeryWithdrawnNCT00882765Phase 2
- Intensity-Modulated Radiation Therapy and Gemcitabine in Treating Patients With Locally Advanced Pancreatic CancerTerminatedNCT00878657Phase 1
- GDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer or Solid Tumors That Cannot Be Removed by SurgeryActive, not recruitingNCT00878163Phase 1
- Direct Tumor Injection KLH-Pulsed Dendritic Cells in Unresectable Pancreatic CancerTerminatedNCT00868114Phase 2
- Pioglitazone as Second-Line in Patients With Metastatic Pancreatic Cancer After Treatment With GemcitabineTerminatedNCT00867126Early Phase 1
- A Study of ARRY-334543 and Gemcitabine in Patients With Advanced Cancer and Pancreatic CancerCompletedNCT00862524Phase 1/2
- Resection in Pancreatic Cancer With Minimal Metastatic Disease or Venous Infiltration Trial at Technische Universität MünchenTerminatedNCT00855634Not applicable
- Role of CXCR2 Ligands/CXCR2 Biological Axis in Pancreatic CancerCompletedNCT00851955
- Safety and Tolerability of AP 12009, Administered I.V. in Patients With Advanced Tumors Known to Overproduce TGF-beta-2CompletedNCT00844064Phase 1
- Reconstruction Following Pancreaticoduodenectomy: A Randomized Clinical Trial of Pancreaticojejunostomy vs PancreaticogastomyCompletedNCT00841607Not applicable
- A Safety, Efficacy and Pharmacokinetic Study of Siltuximab (CNTO 328) in Participants With Solid TumorsCompletedNCT00841191Phase 1/2
- Huachansu & Gemcitabine in Pancreatic CancerCompletedNCT00837239Phase 2
- GI-4000 With Adoptive Transfer in Pancreatic CancerWithdrawnNCT00837135Phase 1
- Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal CancerCompletedNCT00836992
- Minimally Invasive Detection of Lymphatic Micrometastases in Pancreatic CancerCompletedNCT00826982
- Diagnostic Endoscopic Exploration for Pancreatic Head MassTerminatedNCT00816179Not applicable
- Gemcitabine or Gemcitabine and Cisplatin in the Treatment of Advanced Pancreatic CancerStatus unknownNCT00813696Phase 3
- Study of PEP02 as a Second Line Therapy for Metastatic Pancreatic CancerCompletedNCT00813163Phase 2
- A Safety Study Using Pentamidine in Patients With Pancreatic Cancer Undergoing Standard TherapyCompletedNCT00810953Phase 1/2
- Early Enteral Feeding After Pylorus Preserving PancreatoduodenectomyStatus unknownNCT00809081Phase 3
- Intraoperative Celiac Plexus Neurolysis for Patients With Operable Pancreatic and Periampullary CancerCompletedNCT00806611Phase 3
- Identifying the Role of Symptom Outcomes and Biomarkers in Survival in Patients With Metastatic Pancreatic CancerCompletedNCT00805688
- Preoperative Intratumor Dendritic Cells Injection Immunotherapy for Patients With Pancreatic CancerStatus unknownNCT00795977Phase 1/2
- Phase I-II to Evaluate Efficacy/Safety of Sorafenib+Gemcitabine+Radiotherapy in Locally Advanced Pancreatic CarcinomaCompletedNCT00789763Phase 1
- Masitinib in Combination With Gemcitabine for Treatment of Patients With Advanced/Metastatic Pancreatic CancerCompletedNCT00789633Phase 3
- A Phase III Second Line Trial in Advanced Pancreatic Cancer CONKO 003Approved for marketingNCT00786058
- Randomized Phase II Study of FOLFOX Versus FOLFIRI.3 in Gemcitabine-refractory Pancreatic CancerCompletedNCT00786006Phase 2
- Chemotherapy With or Without Enoxaparin in Pancreatic CancerCompletedNCT00785421Phase 2/3
- Opioid Growth Factor (OGF) and Gemcitabine: Novel Treatment for Pancreatic CancerTerminatedNCT00783172Phase 1
- Investigate Role of Metabolic Imaging in Predicting Tumor Response/Outcome After Pancreatic CA TxCompletedNCT00767273Not applicable
- Proton Radiation for Resectable Carcinoma of the PancreasCompletedNCT00763516Not applicable
- Borderline Resectable Pancreatic Cancer: Gemcitabine/Docetaxel and Oxaliplatin Based Chemo/RTCompletedNCT00761241Phase 2
- Metastatic Advanced Pancreas SorafenibStatus unknownNCT00758381Phase 2
- Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United KingdomStatus unknownNCT00757614
- Endoscopic Stenting Versus Surgical Bypass for Low Bile Duct Obstruction by Cancer of the Pancreatic HeadTerminatedNCT00753441Not applicable
- Gemcitabine, Oxaliplatin and Capecitabine for Advanced Pancreatic CarcinomaCompletedNCT00744640Phase 1/2
- A Phase 1 Dose-escalation Study of OSI-906 and Erlotinib (Tarceva®)CompletedNCT00739453Phase 1
- Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic CancerCompletedNCT00733850Phase 2
- Lag-3 and Gemcitabine for Treatment of Advanced Pancreas CancerTerminatedNCT00732082Phase 1
- Screening for Early Pancreatic Neoplasia (Cancer of the Pancreas Screening or CAPS4 Study)CompletedNCT00714701
- A Study of CDX-1307, in Patients With Incurable Breast, Colorectal, Pancreatic, Ovarian or Bladder Cancer (CDX 1307-01)CompletedNCT00709462Phase 1
- Docetaxel Plus Oxaliplatin as Therapy in Patients With Pancreatic CancerStatus unknownNCT00690300Phase 2
- Disease Management Program or Usual Care in Patients With Stage III or Stage IV Lung Cancer, Pancreatic Cancer, Ovarian Cancer, or Colorectal Cancer, and Their CaregiversCompletedNCT00684801
- Human Leukocyte Antigen-A*2402-Restricted Tumor Vessel Specific Peptide Vaccination for Advanced Pancreatic CancerStatus unknownNCT00683358Phase 1/2
- Dose Escalation Study With Zactima and Chemotherapy in Metastatic Pancreas CarcinomaCompletedNCT00681798Phase 1
- DNA Microarray Study of Pancreas CancerCompletedNCT00680420
- Impact of Microparticles on Postoperative Complications in Surgical PatientsCompletedNCT00677781
- First-Line Gemcitabine Chemotherapy With Our Without Sunitinib In Advanced or Metastatic Pancreatic CancerCompletedNCT00673504Phase 2
- Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid TumorsCompletedNCT00667641Phase 1
- NPI-0052 and Vorinostat in Patients With Non-small Cell Lung Cancer, Pancreatic Cancer, Melanoma or LymphomaCompletedNCT00667082Phase 1
- A Single-Patient Study Using AGS 006CompletedNCT00664482Not applicable
- Chemotherapy With or Without Dalteparin in Treating Patients With Metastatic Pancreatic CancerTerminatedNCT00662688Phase 3
- Pancreatic Cancer Collaborative RegistryCompletedNCT00661882
- Venous Thromboembolism and Haemostatic Disturbances in Patients With Upper Gastrointestinal CancerCompletedNCT00660205
- Concurrent Chemo-radiotherapy With Capecitabine for Unresectable Locally Advanced Pancreatic CarcinomaStatus unknownNCT00658840Phase 2
- Study of Respiratory Gated Proton Beam Radiotherapy for Inoperable Pancreas CarcinomaTerminatedNCT00658801Phase 1
- Tight Glycemic Control by Artificial PancreasCompletedNCT00657995Not applicable
- Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer (Phase1/2)CompletedNCT00655785Phase 1/2
- Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal CancerCompletedNCT00654160Phase 1
- Phase 2 Study of S-1 as 2nd Line Therapy in Metastatic Pancreatic CancerCompletedNCT00652054Phase 2
- Phase I Study of CDX-1307, hCG-B Vaccine, for Patients With Incurable, Locally Advanced or Metastatic Breast, Colorectal, Pancreatic, Bladder or Ovarian CancerCompletedNCT00648102Phase 1
- Randomized Controlled Trial of Gemcitabine Combined With 125I BrachytherapyCompletedNCT00644618Phase 3
- The Prognostic Impact of Extracapsular Lymph Node Involvement in Ductal Pancreatic AdenocarcinomaCompletedNCT00644254
- A Study of First Line Treatment With Tarceva (Erlotinib) in Combination With Gemcitabine in Patients With Locally Advanced Unresectable or Metastatic Pancreatic CancerTerminatedNCT00642733Phase 4
- Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic CancerStatus unknownNCT00639925Phase 1
- AdV-tk Therapy With Surgery and Chemoradiation for Pancreas Cancer (PaTK01)CompletedNCT00638612Phase 1
- High Intensity Focused Ultrasound Tumor Treatment for Pancreatic Cancer PainSuspendedNCT00637364Phase 1/2
- Oxaliplatin, Gemcitabine, and Erlotinib Study in Patients With Advanced Chemo-naïve Pancreatic CancerTerminatedNCT00636883Phase 2
- Gemcitabine With or Without Capecitabine and/or Radiation Therapy or Gemcitabine With or Without Erlotinib in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by SurgeryCompletedNCT00634725Phase 3
- Gemcitabine and Capecitabine to Treat Patients With Advanced Pancreatic and Biliary CancersCompletedNCT00626158Phase 1
- Bortezomib and Cetuximab in Treating Patients With Advanced Solid TumorsCompletedNCT00622674Phase 1
- Gemcitabine With Antiangiogenic Peptide Vaccine Therapy in Patients With Pancreatic CancerCompletedNCT00622622Phase 1
- Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid TumorsCompletedNCT00620295Phase 1
- Bevacizumab, Erlotinib and Capecitabine for Advanced Pancreatic CancerCompletedNCT00614653Phase 1
- Low Dose Vaccine Study for Surgically Resected Pancreatic CancerTerminatedNCT00614601Phase 2
- Safety and Efficacy Study of Different Doses of 90Y-hPAM4 Combined With Gemcitabine in Pancreatic CancerCompletedNCT00603863Phase 1/2